Valuation : Vineet Laboratories Limited

Market Cap 558M 5.84M 5.03M 4.77M 4.32M 8.1M 8.15M 56.61M 21.77M 284M 21.94M 21.46M 897M P/E 2024
43.6x
P/E 2025 -1.42x
Enterprise Value 956M 10M 8.62M 8.16M 7.4M 13.88M 13.95M 96.91M 37.27M 486M 37.56M 36.74M 1.54B EV / Sales 2024
587,502x
EV / Sales 2025 890,202x
Free-Float
62.66%
Yield 2024 *
-
Yield 2025 -
26/08 Vineet Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
22/07 Vineet Laboratories Limited Announces Cessation of Gaddam Venkata Ramana to Hold the Office of Managing Director, Effective July 21, 2026 CI
29/05 Vineet Laboratories Limited Announces Resignation of Ramesh Kumar Bandari from Company Secretary and Compliance Officer and Ceases to Be Key Managerial Personnel, Effective May 29, 2026 CI
14/02 Vineet Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
07/02 Vineet Laboratories Limited Approves Appointment of Jasmin Kunal Tailor as Independent Director CI
17/12 Vineet Laboratories says rights issue price set at 30 rupees per share RE
27/11 Vineet Laboratories Gets Board Nod to Raise Up to INR300 Million via Rights Issue MT
27/11 Vineet Laboratories to raise funds up to 300 million rupees via rights issue RE
24/11 Vineet Laboratories to consider rights issue RE
08/11 Vineet Laboratories Limited Announces Resignation of Hari Priya Yerukalapudi as Independent Director, Effective November 08, 2025 CI
17/09/25 Vineet Laboratories Limited Approves the Appointment of Premananda Reddy Vennapusa as Non-Executive Director, Effective from September 15, 2025 CI
22/07/25 Vineet Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
13/05/25 Vineet Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
1 day+3.44%
1 week-0.94%
Current month-4.73%
1 month-5.03%
3 months+8.98%
6 months+23.24%
Current year+0.65%
1 week 35.01
Extreme 35.01
38.78
1 month 35.01
Extreme 35.01
40
Current year 27.96
Extreme 27.96
43.5
1 year 27.96
Extreme 27.96
49.99
3 years 26.51
Extreme 26.51
88.9
5 years 26.51
Extreme 26.51
92
10 years 26.51
Extreme 26.51
124
Manager TitleAgeSince
Director of Finance/CFO 76 01/01/2021
Human Resources Officer - -
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Director/Board Member 57 10/11/2016
Director/Board Member 76 10/11/2016
Chairman 73 16/11/2020
Change 5-day change 1-year change 3-year change Capi.($)
+3.44%-0.94%+9.20%-25.44% 7.44M
-0.65%-2.93%+47.70%+86.17% 994B
-0.29%-3.51%+49.15%+62.35% 640B
+0.83%+0.26%+17.76%+72.25% 454B
-0.38%-3.59%+30.13%+35.17% 337B
-0.09%-13.54%+13.34%+24.95% 261B
-0.43%-2.48%-0.73%+9.58% 246B
-1.34%-13.70%+36.53%+44.96% 204B
-3.44%-7.51%-20.63%-59.44% 190B
-0.75%-4.82%+25.46%+87.14% 178B
Average -0.31%-5.28%+20.79%+33.77% 350.48B
Weighted average by Cap. -0.51%-4.42%+30.96%+54.95%

Financials

2024 2025
Net sales 1.51K 15.8 13.61 12.89 11.68 21.92 22.03 153.11 58.88 768.04 59.35 58.04 2.43K 769.53 8.05 6.94 6.57 5.96 11.17 11.23 78.05 30.01 391.5 30.25 29.59 1.24K
Net income 10.27M 108K 92.63K 87.71K 79.5K 149K 150K 1.04M 401K 5.23M 404K 395K 16.51M -202M -2.11M -1.82M -1.72M -1.56M -2.93M -2.95M -20.48M -7.87M -103M -7.94M -7.76M -325M
Net Debt 441M 4.61M 3.97M 3.76M 3.41M 6.4M 6.43M 44.7M 17.19M 224M 17.33M 16.94M 709M 397M 4.16M 3.58M 3.39M 3.08M 5.77M 5.8M 40.31M 15.5M 202M 15.62M 15.28M 639M
Logo Vineet Laboratories Limited
Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.
Employees
57
Date Price Change Volume
11/09/26 INR 37.02 +3.44% 71,650
10/09/26 INR 35.79 -3.63% 61,159
09/09/26 INR 37.14 +0.54% 73,018
08/09/26 INR 36.94 -0.91% 36,332
07/09/26 INR 37.28 -0.24% 70,769
  1. Stock Market
  2. Stocks
  3. VINEETLAB Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!